Hualan Biological Bacterin (301207.SZ) Earnings Analysis
Hualan Biological Bacterin (301207.SZ) has no confirmed upcoming earnings date. Trailing P/E 53.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 301207.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 301207.SZ. This page updates as the calendar is published.
301207.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-30 | 0.1874 CNY | n/a | n/a | n/a |
| 2025-04-28 | 0.0551 CNY | n/a | n/a | n/a |
| 2024-08-29 | -0.02224 CNY | n/a | n/a | n/a |
301207.SZ valuation and analyst view
| Trailing P/E | 53.26 |
|---|---|
| Trailing EPS | 0.31514 CNY |
| Price / book | 1.75 |
| Dividend yield | 8.27% |
| Market cap | 10.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hualan Biological Bacterin (301207.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 301207.SZ. This page updates as the calendar is published.
Did 301207.SZ beat earnings last quarter?
Consensus estimate data was not available for 301207.SZ's 2025-10-30 report.
What is 301207.SZ's current P/E ratio and EPS?
301207.SZ trades at a trailing P/E of 53.26 on trailing EPS of 0.3151424730448264 CNY.
What do analysts rate 301207.SZ?
301207.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.